首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of pharmaceutical sciences

缩写:EUR J PHARM SCI

ISSN:0928-0987

e-ISSN:1879-0720

IF/分区:5.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引5411
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Cornelia A Karg,Daniel Rüdiger,Fabian Hammerle et al. Cornelia A Karg et al.
Phyllobilins (PBs) are linear tetrapyrroles and represent the only known bilin family originating from chlorophyll rather than heme. Although colorless phylloleucobilins have long been regarded as the predominant chlorophyll metabolites, re...
Chen Jiang,Wei Zhang,Hanmei Ren et al. Chen Jiang et al.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation, for which effective therapeutic strategies remain limited. AdipoRon, a synthetic adiponectin receptor agonist, has been reported to...
Pin-Chen Chen,Yung-Chieh Chang,Yun-Yun Ho et al. Pin-Chen Chen et al.
Indoleamine 2,3-dioxygenase 1 (IDO1) facilitates tumoral immune evasion via the kynurenine (Kyn) pathway, while ABCB1-mediated efflux drives multidrug resistance. Previously, miconazoles were reported as potent IDO1 inhibitors and some azol...
ZiWei Dai,Junqi Su,Xiaofeng Shan et al. ZiWei Dai et al.
Background: Tobacco exposure is a major risk factor for head and neck squamous cell carcinoma (HNSCC), and the tobacco-specific nitrosamine NNK is an established carcinogen. However, the molecular features linking NNK-ass...
Hugo Pardo,Víctor Guarnizo-Herrero,Borja Martínez-Alonso et al. Hugo Pardo et al.
Indomethacin (IND), a Biopharmaceutics Classification System (BCS) Class II drug, exhibits poor aqueous solubility and low dissolution rate, which may limit its oral absorption. In this study, IND cocrystals with benzoic acid (AcBz), theoph...
Elisa Millet,Sofie S T Vandenbroucke,Joseph P O&#x;Shea et al. Elisa Millet et al.
The dynamic and transitory nature of the distal small intestine makes targeted drug delivery to this region particularly challenging. This study aimed to develop a bilayer capsule system for site-specific drug release in the terminal ileum....
Danyang Yun,Lizhen Mu,Juan Liu et al. Danyang Yun et al.
Glioblastoma (GBM) remains the most aggressive primary brain tumor, with poor prognosis largely due to limited drug delivery across the blood-brain barrier (BBB) and insufficient intratumoral penetration. To address these challenges, we dev...
Thanh N Tran Thanh N Tran
Internal Release Limits (IRLs) in pharmaceutical manufacturing are commonly derived using statistical tools originally developed for shelf‑life assignment, most notably time‑series regression and kinetic extrapolation. While appropriate f...
Silvio A B Vieira de Melo,Elaine C M C Albuquerque,Ravenna L Matos et al. Silvio A B Vieira de Melo et al.
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, creating an urgent need for novel therapeutic strategies and advanced manufacturing processes that are scalable and cost-effective. Peptide-based ...
Rubén Del Campo-Montoya,Xavier Mulet I Piera,Marta García-Gómara et al. Rubén Del Campo-Montoya et al.
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, and no current treatment can halt neurodegeneration or restore the nigrostriatal pathway. Although glial cell l...